electroCore (NASDAQ:ECOR) Director Daniel Goldberger Sells 80,000 Shares

electroCore, Inc. (NASDAQ:ECOR) Director Daniel Goldberger sold 80,000 shares of the stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $6.80, for a total value of $544,000.00. Following the completion of the transaction, the director owned 211,471 shares in the company, valued at approximately $1,438,002.80. The trade was a 27.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

electroCore Stock Up 0.7%

ECOR stock opened at $10.25 on Friday. electroCore, Inc. has a twelve month low of $4.16 and a twelve month high of $10.45. The stock’s 50 day moving average is $7.32 and its 200-day moving average is $6.40. The firm has a market capitalization of $85.08 million, a PE ratio of -5.79 and a beta of 0.83.

electroCore (NASDAQ:ECOR) last posted its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.59). The company had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.01 million. electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%. On average, equities research analysts anticipate that electroCore, Inc. will post -1.48 earnings per share for the current fiscal year.

Institutional Trading of electroCore

A number of hedge funds have recently bought and sold shares of the business. NewEdge Advisors LLC increased its position in electroCore by 857.9% in the first quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after buying an additional 145,047 shares during the last quarter. Tejara Capital Ltd purchased a new stake in electroCore in the fourth quarter worth $450,000. DRW Securities LLC purchased a new stake in electroCore in the fourth quarter worth $264,000. WealthShield Partners LLC purchased a new stake in electroCore in the first quarter worth $157,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in electroCore in the first quarter worth $153,000. 26.74% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a report on Friday, March 27th. Zacks Research upgraded electroCore from a “strong sell” rating to a “hold” rating in a report on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, electroCore has a consensus rating of “Hold” and an average target price of $18.00.

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.